Newsroom

Newsroom

Emcure in the News

Newsroom

Press release

Emcure Pharmaceuticals may come up with an IPO of Rs 4000 crore

Emcure Pharma invested 400 cr at Sanand plant

India likely to get first mRNA vax by year-end

Gennova to use mRNA tech to develop Vax for Zika,TB

Emcure Pharma strengthens its board, adds 4 Independent Directors

Emcure to soon file papers for Rs 4,000 crore IPO

Gennova likely to become second vaccine maker to receive advance from Centre

EXPLAINED: Why India-Made Gennova Vax Could Give Protection At A Fraction Of Cost Of Other mRNA Shots

Gennova Likely to Submit Data of Phase-I Trial of India's 1st mRNA Vaccine By This Month

Naveen Soni joins Emcure Pharmaceuticals as Director – Corporate Communications and Public Relations

Emcure says it will continue growth momentum in FY22 by deepening product portfolio, digital focus

Trials of India’s first mRNA Covid vaccine by Gennova on track

Gennova seeks to start trials of indigenous mRNA vaccine

COVID-19: Gennova Biopharma to start mRNA vaccine trials this month

Emcure says Gennova is working on backward integration of its mRNA COVID-19 vaccine

Clinical trials on India's first mRNA Covid-19 vaccine to begin soon

Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate

Emcure Pharmaceuticals Ltd launches Uncondition Yourself - an initiative dedicated to women's health and wellness

Emcure Pharmaceuticals Ltd Launches Uncondition Yourself - an Initiative Dedicated to Women’s Health and Wellness

Emcure Pharmaceuticals Ltd launches Uncondition Yourself - an initiative dedicated to women's health and wellness

Emcure Pharmaceuticals Ltd Launches Uncondition Yourself - an Initiative Dedicated to Women’s Health and Wellness

Quick Explore